The duration that a GLP-1 injection remains active in your system depends primarily on the specific medication and its pharmacokinetic properties
GLP-1based therapy may not be appropriate if you have: -History of medullary thyroid cancer -History of gallbladder disease -History of pancreatitis -Multiple endocrine neoplasia syndrome type 2 (MEN2)
GLP-1 and related medications are usually considered for patients with obesity or overweight plus weight-related medical conditions
Obesity occurs when energy intake is more than whole body expenditure ( Obesity is directly related to the development of cardiometabolic disease (arterial hypertension, coronaric syndrome or heart failure ( Its also associated, in addition, with obstructive sleep apnea (OSAS), non-alcoholic fatty liver disease (NAFLD)/metabolic-associated fatty liver disease (MAFLD), osteoarthritis, gastro-esophageal reflux disease, malignancies (gastrointestinal, liver, breast, and endometrial cancer), and mental health issues, especially in young people
Only about 3% said they could realistically pay over $250 per month, still far below even the current maintenance prices of roughly $350
